Earnings Week Sparks Split Options Bets

Options markets are sending a divided signal heading into one of the year's busiest earnings weeks. Call flows have swamped puts in several large-cap names. At the same time, chips and healthcare are drawing the heaviest bearish pressure.

MRNA is the most striking setup. The stock is up 776% year to date. Analysts now see 46% downside on average. Its short score sits at 49 and the RSI has climbed to 68, pushing into overbought territory ahead of its Q3 earnings call. Options expiries stack from today through January 2027. The risk/reward skew is sharp for anyone holding calls into the print.

Healthcare insurers show a split. HUM is up 63% year to date and carries an ORTEX stock score of 91. ORTEX Alt Data shows Medicare Advantage penetration hit 51.1% in July 2026, the highest reading on record since 2013. That tailwind has drawn bullish positioning. By contrast, options flow in ELV is fully one-sided toward puts this week, with a 0% positive options score.

Chips drew the heaviest negative bets in the broader market. MU, AMD and INTC all topped the negative-bet leaderboard. Micron's RSI sits at just 35, and Intel's has fallen to 23, the lowest among large-cap semis. Chip stocks staged an intraday rebound per headlines, but the options flow has yet to confirm a durable turn.

RKT is worth watching into next week. ORTEX Index Rebalance Radar shows its S&P 500 addition odds jumped overnight from 4% to 31%. A forced buy of $4.1 billion would trade at 17.8 times normal volume if confirmed on 18 December. Elevated call activity around that event window is a natural consequence.

NCLH carries the most tension of any consumer name. Its short score is 64.8 and days-to-cover stands at 5.9. The RSI at 68.8 is close to overbought. That combination of heavy short positioning and rising price creates squeeze potential ahead of its Q3 results.